## 



## 

## 

## 

|||Page|
|---|---|---|
|General<br>information|||
|Report ofthe trustees||3-5|
|Statement<br>oftrustees'|responsibilities||
|Independent<br>auditors'|report|7-10|
|Statement offinancial|activities||
|Balance sheet||12|
|Cashflow statement||13|
|Accounting<br>policies||14 - 15|
|Notes to the financial|statements|16-21|





## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 


## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 



## 

## 

||||Unrestricted||Expendable||Total|Total|
|---|---|---|---|---|---|---|---|---|
||||Income||endowment||this year|last year|
|||Note|Fund||Fund||31.03.23|31.3.22|
|Income resources|||||||||
|Voluntary<br>Income|||||||||
|Donations|||210,000||5,913,960||6,123,960|1,261,111|
|Gift aid refunds|||52,500||||52,500|375,000|
|Investmentincome|||215,725||4,719||220,444|180,789|
|Total incoming<br>recourses|||478 225||5,918,679||6,396,904|1,816,901|
|Resources expended|||||||||
|Cost ofgenerating<br>funds|||||||||
|Investment<br>management|costs||||108,970||108,970|105,371|
|Charitable<br>activities|||||||||
|Grants and donations<br>paid out|||120,000||||120,000|1,643,009|
|Governance<br>cost|||||||||
|Trust accounting/tax<br>claims fees|||9,263||||9,263|9,128|
|Total resources expended|||129,263||108970||238233|1,757 509|
|Net incoming/(outgoing)<br>before transfers|resources||348,963||5,809,709||6,158,671|59,391|
|Gross transfers<br>between|funds||||||||
|Net income/(outgoing)|resources before||||||||
|other recognised<br>gains|and losses||348,963'|.|5,809,709||6,158,671|59,391|
|Other recognised<br>gains|and losses||||||||
|(Losses)/gains<br>on investment<br>assets|||||(961,127)||(961,127)|585,160|
|Net movements<br>in funds|||348,963'||4,848,582|.|5,197,544|644,551|
|Fund balance brought<br>forward at 31 March 2022|||||13,647,167||13,647,167|13,002,616|
|Fund balance carried forward at 31 March 2023|||348,963||18495,748||18,844,711|13,647,167|
||||11||||||





## 

## 

## 

|||||||||Unrestricted|Expendable|||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||Income|Endowment|Total|Total|
|||||||||fund|Fund|this year|last year|
|||||||||||31.3.23|31.3.22|
||||||||Note|||||
|Fixed assets||||||||||||
|Investment|at|market value|||||6|353,614|19,478 250|19,831,864|15,115,329|
|Current assets||||||||||||
|Oebtors||||||||1,010||1 010|78 350|
|Cash at bank||||||||6,039||6,039|36,952|
|Creditors: amounts|||falling|||due within one year|8|(11,700)|(572,502)|(584,202)|(628,464)|
|Net current|assets|||||||~465&|~572,502|~577,153|~513,162|
|Total assets||less current||||liabiiities||348,963|18,905,748|19,254,711|14,602,167|
|Creditors: amounts||||falling||due after one year|||(410,000)|(410,000)|(955,000)|
|I1ietAssets||||||||348,963|18,495 748|18,844,711|13,647,167|
|Funds||||||||||||
|Expendable<br>Unrestricted|endowment<br>income fund||||fund|||||18,495,748<br>348 963<br>18,844,711|13,647,167<br>13,647,167|





## 

## 

||Note|31.3.23|31.3.22|
|---|---|---|---|
|Net income for the year||6,158,671|59,391|
|Adjustments<br>for||||
|Interest and dividends<br>Decrease/(Increase)<br>in debtors<br>(Decrease)/Increase<br>in creditors||(220,444)<br>7?,340<br>(589,262)|(180,789)<br>(70,549)<br>958,124|
|Cash flows from operating<br>activities||5,426,305|766,177|
|Cash flows from investing<br>activities||||
|Interest and dividends<br>Proceeds from sale of investments||220,444<br>10,499,291|180,789<br>4 718654|
|Purchase ofinvestments||(11,681,866)|(6,219,257)|
|Net cash used by investing<br>activities||(962,131)|(1,319,814)|
|Change<br>in cash and cash equivalents<br>Cash and cash equivalents<br>brought<br>forward<br>Cash and cash equivalents<br>carried forward|12|4,464,173<br>681,848<br>5,146,021|(553,637)<br>1,235,484<br>681,848|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|||||||||31.3.23|31.03.22|
|---|---|---|---|---|---|---|---|---|---|
|1|Investment<br>income|||||||||
||UKlncome<br>Interest|||||||22,420|10,178|
||Dividends|||||||33,780|21,710|
||Accumulated|Dividends||- Expendable||endowment||3,616|2,861|
||Property|||||||12,533|21,832|
||Overseas<br>Income<br>Interest|||||||65,996|48,417|
||Excess reportable<br>Dividends||income - Expendable||||endowment|1,103<br>80,995|2,298<br>73,493|
||Property|||||||||
||Investment<br>income is unrestricted|unless otherwise|||stated|||220,444|180,789|
|2|Raising funds|||||||||
||Portfolio management<br>Less repaid commission|||||||108,970<br>108,970|107,733<br>2,362<br>105,371|
|3|Grants made|||||||||
||The total grants made to institutions||during|the years was||as|follows:|||
||Medecins San Frontieres||||||||190,000|
||Supporting<br>Dalit Children<br>Marie Curie Cancer Care||||||||50,000<br>130,000|
||Mary's Meals<br>St Mungo's<br>Breast Cancer Now||||||||105,000<br>105,000<br>20,000|
||Prostate Cancer UK||||||||140,000|
||Youngminds<br>Fair Trials International||||||||75,000<br>55,000|
||StGiles Trust||||||||85,000|
||Hardman<br>Trust||||||||70,000|
||Anne Robson Trust||||||||55 000|
||Mind||||||||130,000|
||Herts Young Homeless<br>Big issue Foundation<br>Uhlock||||||||60,000<br>45,000<br>10,000|
||Cerabral<br>Palsy Alliance Reseach<br>SCI Foundation||||||||509<br>190,000|
||Arrhythmogenic<br>Cardiomyopathy||||||||500|





## 

## 

|||31.3.23|31.03.22|
|---|---|---|---|
|Grants made. ...continued|||E|
|Macmillian<br>Cancer Support<br>John Clemments<br>Sports 8 Community<br>Isobel Hospice<br>Ltd<br>Haileybury<br>Youth Trust<br>Samaritans<br>Footsteps Foundation<br>Tree Aid<br>Envision<br>The Haileybury<br>Youth Trust<br>British Heart Foundation<br>Barts Charity<br>Samaritans|Trust|1,000<br>35,000<br>1,000<br>8,000<br>5,000<br>50,000<br>20,000|5,000<br>1,000<br>50,000<br>20,000<br>20,000<br>25,000<br>1,000<br>5,000|
|||120,000|1,643,009|



||Further<br>detail|on commitments<br>and on the actual cash disburs|ed<br>in the year is provided<br>in note 14.||
|---|---|---|---|---|
|4|Governance|costs|||
||Handelsbanken<br>Audit fee<br>Other|Wealth Management|6,000<br>2,700<br>563|6,000<br>2,700<br>428|
||||9,263|9,128|





## 

## 

||||||||2023|2022|
|---|---|---|---|---|---|---|---|---|
||||||||F|F|
|5|Analysis of Funds||At<br>01-Apr-22||Income|Expenditure|Gains losses<br>&transfers|At<br>31-Mar-23|
||||restated||||||
||||F||F|F||F|
||Unrestricted<br>income funds<br>Expendable<br>endowment<br>funds||13,647,167||478,225<br>5,918,679|(129,263)<br>(108,970)|(961,127)|348,963<br>18,495,748|
||||13647,167||6,396,904|~238,233|||
||||At||Income|Expenditure|Gains losses|At|
||||01-Apr-21||||&transfers|31-Mar-22|
||||||F|F.||F|
||Unrestricted<br>income funds<br>Expendable<br>endowment<br>funds||0<br>13,002,616||175,630<br>1,641,271|(1,652,138)<br>(105,371)|1,476,508<br>(891,348)|13,647,167|
||||13,D02,617||1,816 9D1|~1,757,509|||
|6|Market value<br>Carry (market) value at beginning<br>ofyear<br>Add Additions<br>at cost<br>Less disposals at carry value<br>Add/(deduct)<br>net gain/(loss)<br>on revaluation<br>Carry (market) value at end ofyear||||||14,470,432<br>11,681,866<br>(10,499,291)<br>961,127<br>14,691,881|12,384,669<br>6,219,257<br>(4,718,654)<br>585,160<br>14,470,432|
||Shares<br>Portfolio Cash||||||14,691,881<br>5,139,983<br>19,831,864|14,470,432<br>644,897<br>15,115,329|
||Realised gains/(loss)<br>Unrealised<br>gains/(loss)|on revaluation|||||(430,621)<br>530506<br>961 127|499,123<br>86,037<br>585,160|
||The historic cost ofthese investments<br>was|||f13,258,748 (2022: F12,321,275)|||||
|7|Oebtors||||||||
||Prepayments<br>and accrued income<br>Gift aid refunds||||||1,010<br>1,010|3,350<br>75,000<br>78,350|
|8|Creditors: amount<br>falling due||within one year||||||
||Accruals and deferred<br>Donation commitments|income|||||39,202<br>545,000|38,464<br>590,000|
||||||||584 202|628,464|
||||||18||||





## 

## 

|9 Creditors: amount|falling due after one year|||||
|---|---|---|---|---|---|
|Donation<br>commitments||||410,000|955,000|
|||||410,000|955,000|
|10 Analysis<br>of Net Assets between funds||||||
|Fund balances as at|31 March 2023 are represented|by:||Expendable||
||||Unrestricted|endowment|Total|
||||Funds|Funds|Funds|
||||E|||
|Fixed assets|||353,614|19,478,250|19,831,864|
|Current assets|||7,049||7,049|
|Current<br>liabilities|||(11,700)|(572,502)|(584,202)|
|Non-current<br>liabilities||||(410,000)|(410,000)|
|Total net assets|||348,983|18498748|18844711|
|Analysis ofNet Assets between funds||||||
|Fund balances as at|31 March 2022 are represented|by:||Expendable||
||||Unrestricted|endowment|Total|
||||Funds|Funds|Funds|
||||F||P|
|Fixed assets||||15,115,329|15,115,329|
|Current assets|||11,700|103,602|115,302|
|Current<br>liabilities|||(11,700)|(616,764)|(628,464)|
|,Non-current<br>liabilities||||(955,000)|(955,000)|
|Total net assets||||13647 167|13647 167|





## 

## 

## 

## 

||3Ts trust in the year en|3Ts trust in the year en|ded 31 March 2022.|||||
|---|---|---|---|---|---|---|---|
|12|Analysis of cash and||cash equivalents|||2023|2022<br>f|
||Cash|in hand||||6,039|36,952|
||Cash|held within investments||||5,139,983|644,896|
|||||||5,146,022|681,848|
|13|Analysis ofchanges||in net debt|||||
|||||At 1 April|Cash flows|Other non-|At 31 March|
|||||2022||cash|2023|
|||||||Changes||
|||||||F||
||Cash|||36,952|(30,913)||6,039|
||Cash|equivalents||644,896|4,495,087||5,139,983|
|||||681,848|4,464,173||5,146,022|
||Loans|falling due within|one year|||||
||Finance lease obligations|||||||
|||||681 848|4464,173||5 146,022|





## 

|St Giles Trust||75,000|
|---|---|---|
|St Mungo's||105,000|
|Young Minds||60,000|
|Prostate Cancer UK||105,000|
|SCI Foundation||150,000|
|Herls Young Homeless||60,000|
|Hardman<br>Trust||60,000|
|Marie Curie||105,000|
|Fair Trials International||45,000|
|Mary's Meals||105,000|
|Mbdecins<br>san Frontihres||150,000|
|Anne Robson Trust||45,000|
|Big Issue Foundation||45,000|
|Mind||105,000|
|Dalit Children||30 DOO|
|||1,245,000|
|Add pre-existing|commitments|300,000|
|||1,545,000|
|Less paid in Year ended 31 March 2023||590,000|
|||955,0DD|



|Year|ended|31|March|2024|545,000|
|---|---|---|---|---|---|
|Year|ended|31|March|2025|410000|
||||||955 000|





## 

## 

## 

